Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.
Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
Seems to me that the release of the 10q was intended to be near the Case Managment Conference, knowing that PTSC brought the Shares outstanding from 489 Million to 410 Million, could the price suppression be due to the fact that more shares need to be bought back?
